Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Enhertu recommended for EU approval in gastric
Investegate announcements from AstraZeneca PLC, Enhertu recommended for EU approval in gastric
Source: investegate.co.uk
📰 Human Use News
Page 104 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
Stelis receives a positive recommendation from EMA granting market authorization for Kauliv™
Stelis Biopharma Ltd announced that its product division Biolexis has a major success with its first biosimilar product Kauliv™ receiving a positive recommendation from European Medicines Agency for granting of market authorization.
Strides Pharma Science Limited European Medicines Agency Strides Pharma Science Stelis Biopharma Limited Or Company Owen Mumford Limiteda United Kingdom Based Committee For Medicinal Products Human Use
Source: equitybulls.com
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Imfinzi recommended for approval in the EU for BTC
Investegate announcements from AstraZeneca PLC, Imfinzi recommended for approval in the EU for BTC
Source: investegate.co.uk
EMA human medicines committee highlights, November 2022
EMA's human medicines committee's November meeting recommended approval of four medicines, including a biosimilar for osteoporosis.
Sugammadex Amomed Vidprevtyn Beta Pirfenidone Viatris European Union European Medicines Agency Committee For Medicinal Products Human Use
Source: europeanpharmaceuticalreview.com
AstraZeneca's Imfinzi recommended for approval in EU for BTC
AstraZeneca's Imfinzi recommended for approval in EU for BTC
United Kingdom South Korea Juanw Valle Susan Galbraith European Society For Medical Oncology Congress European Union
Source: directorstalkinterviews.com
UCB announces U.S. FDA acceptance of new drug application and EMA MAA validation for zilucoplan for the treatment of generalized myasthenia gravis in adult patients
New drug application (NDA) for zilucoplan seeks approval for the treatment of generalized myasthenia gravis (gMG) in adult patients who are acetylcholine...
Source: prnewswire.com
Imfinzi plus chemotherapy recommended for approval in the EU by CHMP as first immunotherapy regimen for advanced biliary tract cancer
AstraZeneca’s Imfinzi (durvalumab) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line treatment of adult patients with unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy (gemcitabine plus cisplatin). The Committee for Medicinal Products ...
Source: pharmiweb.com
Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2022 Earnings Call Transcript
Amylyx Pharmaceuticals, Inc. (NASDAQ:NASDAQ:AMLX) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Lindsey Allen - Head of Investor Relations and...
Source: seekingalpha.com
Stada and Xbrane gain EU approval for biosimilar Ximluci
Partnership combines Xbrane’s protein-expression system with Stada’s management teams - News - PharmaTimes
Peter Goldschmidt European Medicines Agency European Commission Committee For Medicinal Products Human Use Medicinal Products Human Use
Source: pharmatimes.com